Viemed Healthcare (NASDAQ:VMD) Shares Up 1.2% – Time to Buy?

Viemed Healthcare, Inc. (NASDAQ:VMD) shares shot up 1.2% on Thursday . The company traded as high as $10.08 and last traded at $10.01. 228,480 shares were traded during mid-day trading, a decline of 10% from the average session volume of 254,562 shares. The stock had previously closed at $9.89.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 14th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold”.

Viemed Healthcare Trading Down 1.7%

The business’s 50-day moving average is $9.51 and its two-hundred day moving average is $8.30. The company has a current ratio of 1.22, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $377.24 million, a PE ratio of 26.59 and a beta of 1.15.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.The business had revenue of $75.41 million for the quarter, compared to analysts’ expectations of $74.40 million. On average, analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.

Insiders Place Their Bets

In related news, President Michael Moore sold 65,000 shares of the company’s stock in a transaction on Friday, March 20th. The shares were sold at an average price of $8.77, for a total transaction of $570,050.00. Following the completion of the sale, the president directly owned 1,585,812 shares of the company’s stock, valued at approximately $13,907,571.24. This represents a 3.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last three months, insiders have sold 136,802 shares of company stock worth $1,237,976. 20.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Viemed Healthcare

A number of institutional investors have recently added to or reduced their stakes in VMD. State of Alaska Department of Revenue purchased a new position in Viemed Healthcare in the 4th quarter valued at about $25,000. Kemnay Advisory Services Inc. purchased a new position in Viemed Healthcare in the 4th quarter valued at about $46,000. Quarry LP purchased a new position in Viemed Healthcare in the 3rd quarter valued at about $48,000. Diversified Trust Co purchased a new position in Viemed Healthcare in the 1st quarter valued at about $107,000. Finally, AQR Capital Management LLC purchased a new position in Viemed Healthcare in the 1st quarter valued at about $90,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.